Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8116 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.8082 |
Intermediate Similarity |
NPD7236 |
Approved |
0.7987 |
Intermediate Similarity |
NPD8470 |
Clinical (unspecified phase) |
0.7933 |
Intermediate Similarity |
NPD7239 |
Suspended |
0.7863 |
Intermediate Similarity |
NPD2629 |
Approved |
0.784 |
Intermediate Similarity |
NPD8368 |
Discontinued |
0.7823 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7812 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.773 |
Intermediate Similarity |
NPD7008 |
Discontinued |
0.7711 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD8407 |
Phase 2 |
0.7674 |
Intermediate Similarity |
NPD6831 |
Clinical (unspecified phase) |
0.7643 |
Intermediate Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD8361 |
Approved |
0.7619 |
Intermediate Similarity |
NPD8360 |
Approved |
0.7605 |
Intermediate Similarity |
NPD8424 |
Clinical (unspecified phase) |
0.7594 |
Intermediate Similarity |
NPD5951 |
Approved |
0.7584 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7515 |
Intermediate Similarity |
NPD8435 |
Approved |
0.75 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7468 |
Intermediate Similarity |
NPD7058 |
Phase 2 |
0.7468 |
Intermediate Similarity |
NPD7057 |
Phase 3 |
0.7424 |
Intermediate Similarity |
NPD2181 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD4198 |
Discontinued |
0.7405 |
Intermediate Similarity |
NPD2182 |
Approved |
0.7391 |
Intermediate Similarity |
NPD7163 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD3412 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD7741 |
Discontinued |
0.7356 |
Intermediate Similarity |
NPD8485 |
Approved |
0.7338 |
Intermediate Similarity |
NPD6273 |
Approved |
0.731 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7308 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD7702 |
Clinical (unspecified phase) |
0.726 |
Intermediate Similarity |
NPD7961 |
Discontinued |
0.7237 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7233 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7232 |
Intermediate Similarity |
NPD8486 |
Clinical (unspecified phase) |
0.7211 |
Intermediate Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD6591 |
Clinical (unspecified phase) |
0.7193 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7171 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7164 |
Intermediate Similarity |
NPD4141 |
Clinical (unspecified phase) |
0.7163 |
Intermediate Similarity |
NPD6287 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD6663 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7133 |
Intermediate Similarity |
NPD7305 |
Phase 1 |
0.7126 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7122 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7118 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7118 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7103 |
Intermediate Similarity |
NPD5736 |
Approved |
0.7099 |
Intermediate Similarity |
NPD164 |
Approved |
0.7099 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7092 |
Intermediate Similarity |
NPD7457 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7063 |
Intermediate Similarity |
NPD37 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6858 |
Approved |
0.7059 |
Intermediate Similarity |
NPD7094 |
Approved |
0.7054 |
Intermediate Similarity |
NPD1238 |
Approved |
0.7051 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7044 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7039 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7037 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7037 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7023 |
Intermediate Similarity |
NPD1930 |
Approved |
0.7023 |
Intermediate Similarity |
NPD1929 |
Approved |
0.7023 |
Intermediate Similarity |
NPD6647 |
Phase 2 |
0.7023 |
Intermediate Similarity |
NPD1931 |
Clinical (unspecified phase) |
0.7019 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7013 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7011 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD6764 |
Approved |
0.7 |
Intermediate Similarity |
NPD6765 |
Approved |
0.6974 |
Remote Similarity |
NPD2935 |
Discontinued |
0.697 |
Remote Similarity |
NPD1237 |
Approved |
0.697 |
Remote Similarity |
NPD5909 |
Discontinued |
0.6968 |
Remote Similarity |
NPD6190 |
Approved |
0.6968 |
Remote Similarity |
NPD7274 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD690 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD6801 |
Discontinued |
0.6937 |
Remote Similarity |
NPD6599 |
Discontinued |
0.6936 |
Remote Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6933 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6932 |
Remote Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD6232 |
Discontinued |
0.6928 |
Remote Similarity |
NPD7266 |
Discontinued |
0.6923 |
Remote Similarity |
NPD2066 |
Phase 3 |
0.6914 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6914 |
Remote Similarity |
NPD5760 |
Phase 2 |
0.6914 |
Remote Similarity |
NPD5761 |
Phase 2 |
0.6913 |
Remote Similarity |
NPD7715 |
Approved |
0.6913 |
Remote Similarity |
NPD7714 |
Approved |
0.6908 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6887 |
Remote Similarity |
NPD3528 |
Clinical (unspecified phase) |
0.6884 |
Remote Similarity |
NPD6010 |
Discontinued |
0.6871 |
Remote Similarity |
NPD5402 |
Approved |
0.6871 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6863 |
Remote Similarity |
NPD5404 |
Approved |
0.6863 |
Remote Similarity |
NPD5406 |
Approved |
0.6863 |
Remote Similarity |
NPD5408 |
Approved |
0.6863 |
Remote Similarity |
NPD5405 |
Approved |
0.6863 |
Remote Similarity |
NPD2438 |
Suspended |
0.6861 |
Remote Similarity |
NPD1609 |
Clinical (unspecified phase) |
0.6855 |
Remote Similarity |
NPD5403 |
Approved |
0.6848 |
Remote Similarity |
NPD6234 |
Discontinued |
0.6846 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6839 |
Remote Similarity |
NPD6784 |
Approved |
0.6839 |
Remote Similarity |
NPD6785 |
Approved |
0.6838 |
Remote Similarity |
NPD2067 |
Discontinued |
0.6835 |
Remote Similarity |
NPD2534 |
Approved |
0.6835 |
Remote Similarity |
NPD2532 |
Approved |
0.6835 |
Remote Similarity |
NPD8389 |
Clinical (unspecified phase) |
0.6835 |
Remote Similarity |
NPD2533 |
Approved |
0.6821 |
Remote Similarity |
NPD230 |
Phase 1 |
0.6818 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6818 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6818 |
Remote Similarity |
NPD5762 |
Approved |
0.6818 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6818 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6818 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6818 |
Remote Similarity |
NPD5763 |
Approved |
0.6818 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6809 |
Remote Similarity |
NPD7610 |
Discontinued |
0.6806 |
Remote Similarity |
NPD4806 |
Approved |
0.6806 |
Remote Similarity |
NPD4807 |
Approved |
0.6803 |
Remote Similarity |
NPD5740 |
Clinical (unspecified phase) |
0.6803 |
Remote Similarity |
NPD6085 |
Phase 2 |
0.6802 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.6802 |
Remote Similarity |
NPD6559 |
Discontinued |
0.68 |
Remote Similarity |
NPD8032 |
Phase 2 |
0.68 |
Remote Similarity |
NPD7713 |
Phase 3 |
0.6797 |
Remote Similarity |
NPD3748 |
Approved |
0.6795 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6795 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6791 |
Remote Similarity |
NPD5048 |
Discontinued |
0.679 |
Remote Similarity |
NPD7411 |
Suspended |
0.6788 |
Remote Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.6783 |
Remote Similarity |
NPD2932 |
Approved |
0.6783 |
Remote Similarity |
NPD5306 |
Approved |
0.6783 |
Remote Similarity |
NPD5305 |
Approved |
0.6781 |
Remote Similarity |
NPD1283 |
Approved |
0.6774 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.6772 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6765 |
Remote Similarity |
NPD7228 |
Approved |
0.6759 |
Remote Similarity |
NPD1608 |
Approved |
0.6755 |
Remote Similarity |
NPD2979 |
Phase 3 |
0.6755 |
Remote Similarity |
NPD4140 |
Approved |
0.6747 |
Remote Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.6741 |
Remote Similarity |
NPD6685 |
Approved |
0.6735 |
Remote Similarity |
NPD2797 |
Approved |
0.6735 |
Remote Similarity |
NPD1470 |
Approved |
0.6733 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6732 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.673 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.673 |
Remote Similarity |
NPD5401 |
Approved |
0.6725 |
Remote Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.672 |
Remote Similarity |
NPD8462 |
Phase 1 |
0.6718 |
Remote Similarity |
NPD9495 |
Approved |
0.6711 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6707 |
Remote Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.669 |
Remote Similarity |
NPD1201 |
Approved |
0.6689 |
Remote Similarity |
NPD2798 |
Approved |
0.6688 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6667 |
Remote Similarity |
NPD3817 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD7095 |
Approved |
0.6667 |
Remote Similarity |
NPD8404 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD3019 |
Approved |
0.6667 |
Remote Similarity |
NPD6799 |
Approved |
0.6667 |
Remote Similarity |
NPD8651 |
Approved |
0.6667 |
Remote Similarity |
NPD7798 |
Approved |
0.6667 |
Remote Similarity |
NPD5122 |
Clinical (unspecified phase) |
0.6647 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.6647 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6646 |
Remote Similarity |
NPD1934 |
Approved |
0.6645 |
Remote Similarity |
NPD1551 |
Phase 2 |
0.6645 |
Remote Similarity |
NPD6100 |
Approved |
0.6645 |
Remote Similarity |
NPD6099 |
Approved |
0.6645 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6644 |
Remote Similarity |
NPD3972 |
Approved |
0.6643 |
Remote Similarity |
NPD4869 |
Clinical (unspecified phase) |
0.6625 |
Remote Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.6623 |
Remote Similarity |
NPD3268 |
Approved |
0.6623 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6621 |
Remote Similarity |
NPD4106 |
Approved |
0.6621 |
Remote Similarity |
NPD4136 |
Approved |
0.6621 |
Remote Similarity |
NPD4135 |
Approved |
0.662 |
Remote Similarity |
NPD9493 |
Approved |
0.6613 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6613 |
Remote Similarity |
NPD8319 |
Approved |
0.659 |
Remote Similarity |
NPD7074 |
Phase 3 |
0.6589 |
Remote Similarity |
NPD1088 |
Approved |
0.6582 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6581
|
Remote Similarity |
NPD7033 |
Discontinued |